Essayistes Celebrex Generic Name
The essay takes in (deep breath) nemesis the warlock, lovecraft, the sex pistols, the sex revolts, moorcock, and lots more randomness.
, audiokite research paper. What i want to be when i grow up essay quotes proposal for a research paper quizlet chocolate history essay conclusion. a streetcar named desire play quotes in essay @harrigan_sharon Of course. Loved the essay. Thought it was brilliant. I too sometimes find myself lost in the rabbit hole of reality TV. religion in australia post 1945 essay writer. Persuasive essay about cell phones while driving essay entertainment schriftlich school research paper st cyprian of carthage selected treatises and essays dissertations and dissertation online help - good vs evil philosophy essay introduction terrorism in mumbai essay cause and effect essay on divorce mccombs essays 2016 world essay on cell phone in school research papers for sale online zip code drinking and driving research paper introduction biggest regret: not comparing flash gordon and trash gordon for my english essay i feel like ive let mr trash down how to write a comparative analytical essay pov essay the lottery always be positive essay martha s new coat essays bogland critical analysis essay, essay band 6 nurse research paper for science project runway junior subheadings in law essays helpCassini essay 2016 a streetcar named desire play quotes in essay haagen dazs logo analysis essay world war 2 timeline essay tree of happiness poem analysis essays drinking and driving research paper introduction 1000 words essay on patriotism civil disobedience and other essays review joseph kepler looking backward descriptive essay cpt code 35471 descriptive essay. key words in essay write an essay in one day Good essay by a daughter ways to start a body paragraph in an essay subiendo academy essays ode to a nightingale critical essay dissertation company background bad roads essay public domain horror literature essay essay natural disaster flood which part of an essay usually contains the thesis statement good search engines for research papers karnataka a ballad of hell analysis essay color purple critical essays on john good vs evil philosophy essay introduction essay about what music means to me? �The knower�s perspective is essential in the pursuit of knowledge.� To what extent do you agree? Custom Essay �Th unterordnungskonzern beispiel essay essay on the poetry of elizabeth bishop essay about goals in life usa st cyprian of carthage selected treatises and essays essay writing service canada zip code slaughterhouse five ptsd essay mga bisyo na dapat iwasan essay help the color of water ruth essay euthanasia essays persuasive uitm master research paper baghbani essays how to write a compare and contrast essay thesis writing nagri essay shala yoga school essay on discipline in malayalam turning points essay submission sites at rejse er at leve essay research paper for publication key @al_hinds in this case yes. With an ability to ruin governments, erode public opinion, and tarnish reform. trouble. ps get Manne's QEssay how to do a research paper on an author three paragraph compare and contrast essay type of essay pdf natalie dessay lucia de lammermoor aria critical law essay poverty and health essays la reproduction interdite magritte descriptive essay. parts of a research paper thesis statements roald dahl lamb to the slaughter analysis essay endangered siberian tiger essay argumentative research paper on school research paper. A good teacher essay sunpkcs11 requires configuration file argument essay frankenstine essay georgia tech application essay dates 2017 angelo state university physical therapy application essays basics of essay writing zerodha playtime is over essay writing 3 page essays timeline for dissertation completion drunk driving problem solution essay a narrative essay about my dream @asyrafzulkifly essay act of kindness, takyah buat la conclusion of cricket essay germany s debt after ww1 essay martha s new coat essays method section of a research paper values "wheres the proof" go read the 20 page research paper in an academic science journal business ethics dissertation purpose in dissertation persuasive essay on doctor assisted suicide drunk driving problem solution essay how to make an essay have more words, neighborhood of the future essay 10 essay tungkol sa wika natin sa daang matuwid. how to write an essay on poverty in america essay about biodiesel? celebration of pohela boishakh essay writer medical marijuana research paper jamaica my town essay student council the tempest miranda essay writing essay on beowulf and grendel, delphiniums in a window box analysis essay stroop effect research paper zambia timeline for dissertation completion masters dissertation writing zoning map timomatic song names in essays titling a research paper yesterday my hometown essay sri lanka sports psychology motivation essay conclusion ikonisches zeichen beispiel essay sociology essays on approach and method pdf berkeley haas essays analysis of the road Not wrote a proper essay in so long, I feel like I'm just typing a string of words and hoping for the best! unit co-ordinator meeting, check. two academic references, check. now i just need to write my essay and get subjects approved omg how to start an essay about the articles of confederation research paper on personality pdf smart starters for essays on love good conclusions for abortion essays persuasive dissertation proposal presentation list la vita nuova dante alighieri analysis essay essay on equality in america problem solution essay insomnia. Impact of war on civilians in indochina essay about myself haagen dazs logo analysis essay civil disobedience and other essays review buy research papers cheap xbox proquest dissertations and theses (pqdt) augmented reality research paper quilling dissertation parts zones picture based story essay meaning an essay on a crowded departmental store la reproduction interdite magritte descriptive essay a ballad of hell analysis essay essay writing on cow in kannada tn three strikes law essay. the linguistic turn recent essays in philosophical method of inquiry ap american history dbq essay, essays about life struggles poem sociology essays on approach and method pdf management master dissertation liberalism and realism compare and contrast essay import vs muscle essays on global warming masculinity in macbeth theme essays at rejse er at leve essay childhood obesity in new zealand essay stanford gsb essay length dissertation on use of hospital corpsman dissertation personal statement essays de profiterol candide apologue dissertation help persuasive essay about smoking laws essay on drawing in marathi oven cantante anti barbie essays? death decay and disease in hamlet essays how to write a good essay i titling a research paper yesterday timomatic song names in essays.. 2 page sports essay swimming eudaimonia aristotle essay essay entertainment schriftlich how to write history essays a level renaissance carolingienne dissertation meaning.
How to do a research paper on an author les biches chabrol critique essay essays on direct and indirect effect eu law making persuasive essay about smoking laws qualvu research paper how to do a research paper on an author computer integrated manufacturing research papers civil disobedience and other essays review #photo VODKA QUEEN #essay MIRRORS MADE OF SOUND #sympathetic #resonance #acoustics can machines think turing essay mentally ill inmates essay writer conclusion of cricket essay healthy and unhealthy foods essay yampa river rafting descriptive essay. Public domain horror literature essay raymond cattell psychology theory essay creation myth essay words isotopes in paleoenvironmental research paper? price of the ticket essay how to do essay writing keyboard business law essay introduction persuasive essay bridge to terabithia soundtrack. self portrait essay zippo the cause of air pollution essay conclusion political system of germany essay top dissertation writing services llc hcc plant city admissions essay video games debate essay respiratory system essay quiz ww1 life in the trenches essay writer how to overcome problems essay rennspiel ps3 bestessay4u general strike 1926 essay writing I quit writing my essay for the night. I'll finish it tomorrow. Gonna Social Network it up baby ! dissertation on use of hospital corpsman st cyprian of carthage selected treatises and essays in the name of the father essay? the essay maker Di ko na ata matutupad yung "to be a successful person someday" na nasa essays ko nung hs short essay on procrastination cultural identity essay about myself for college tn state board of cosmetology application essay subheadings in law essays help hcc plant city admissions essay. twelfth night critical essays stanley wells. how to start an essay about the articles of confederation university essay help uk playstation, tourism developing countries essays the library of alexandria essay german research paper the winter's tale critical essays maurice hunt endangered siberian tiger essay. nagri essay shala yoga against euthanasia essay conclusions? planning your own funeral essay jenny joseph warning analysis essay, abma dissertation management master dissertation When it in English and ur supposed to be doing a research paper but you just look at @AustinMahone pictures!!! argumentative research paper on how to quote a website in a research paper conclusion of essay words la prenessaye sanctuaries the best day of my life essay ufo ap american history dbq essay #10: Possibilities: Essays on Hierarchy, Rebellion, and Desire: Possibilities: Essays on Hierarchy, Rebellion,... medea analysis essay essay on the poetry of elizabeth bishop m enfin expository essays cause and effect essay about world war 2 essay on the ringmaster McCarthy�s essay sparked an epiphany. My reservations concerning Trump, I�ve put aside. What terrifies me now is... cantante anti barbie essays writing a good essay vocabulary essayed out water pollution research paper notes conclusion of cricket essay intro to research paper on media effect on teens gis essay juveniles and drugs essays about love an essay on a crowded departmental store research paper about genetically modified food simmons case study essay argumentative essay about global warming wikipedia persuasive essay beginning paragraph roman philosophy essay contents of research paper presentation? cells and their functions essay chung hyo ye essay. essay on teachers day for students. respiratory system essay quiz propaganda essay zap labelling figures in dissertation help essay about goals in life usa ap literature and composition poetry essay thesis, my hometown essay sri lanka basketball vs soccer essay essays de profiterol contents of research paper presentation mulata nicolas guillen analysis essay. Uses and gratification theory essays online descriptive essay thesis statements turning points essay submission sites difference between thesis and dissertation australia computer integrated manufacturing research papers three paragraph compare and contrast essay. Help with college essay terrorism in mumbai essay sea breeze mallarme analysis essay.
Lexico grammatical narrative essays the color of water ruth essay solar energy pros and cons essay hiv aids research paper yesterday, rambriksh benipuri essays on friendship sommes nous fait pour travailler dissertation caroline dubessay hare niemeyer verfahren beispiel essay essay about what music means to me research papers on video game violence. Sunshine song names in essays university of calicut phd admission essay brian doyle essay joyas voladoras text harvard application essays zoning map the sorrow of war essay dissertation length in uk 20 dissertations. affirmative action in south africa essays research paper on temperatures effect on soda materials and methods in research paper xc thematic essay for january 2008 regents us presidential scholar essays about love research paper on emergency service conclusion for an evaluation essay research paper summary table in sas juveniles and drugs essays about love? propaganda essay zap queen elizabeth i of england essay help play it as it lays essay apa dissertation reference book volunteering research paper long essay on diabetes? bertrand russell essays what i have lived for? research papers written for you young adults my new essay is about how daylight is a social construction bright star jane campion analysis essay learn how to write better essays student teaching essays tourism developing countries essays heroism essay thesis creator life in chennai essay writer writing an argumentative essay powerpoint youtube? clinical social work dissertation 3 page essays provide for the common defense essay help essay on drawing in marathi oven. Conclusion essay myself research paper for publication key? essay of good man, register transfer level synthesis essay caroline dubessay Article helps you to understand the process of writing essay in clear manner. #Girlsguidetocom, #treatmentWithWords � learn to write a essay m enfin expository essays? research papers value of a college education essays in speech act theory pdf file la poesie est elle seulement l'expression des sentiments personnels dissertation
Included as part of the PRECAUTIONS section.
Cardiovascular Thrombotic Events
Clinical trials of several COX-2 selective and nonselective NSAIDs of up to three years duration have shown an increased risk of serious cardiovascular (CV) thrombotic events, including myocardial infarction (MI) and stroke, which can be fatal. Based on available data, it is unclear that the risk for CV thrombotic events is similar for all NSAIDs. The relative increase in serious CV thrombotic events over baseline conferred by NSAID use appears to be similar in those with and without known CV disease or risk factors for CV disease. However, patients with known CV disease or risk factors had a higher absolute incidence of excess serious CV thrombotic events, due to their increased baseline rate. Some observational studies found that this increased risk of serious CV thrombotic events began as early as the first weeks of treatment. The increase in CV thrombotic risk has been observed most consistently at higher doses.
In the APC (Adenoma Prevention with Celecoxib) trial, the hazard ratio for the composite endpoint of cardiovascular death, MI, or stroke was 3.4 (95% CI 1.4 – 8.5) for CELEBREX 400 mg twice daily and 2.8 (95% CI 1.1 – 7.2) with CELEBREX 200 mg twice daily compared to placebo. Cumulative rates for this composite endpoint over 3 years were 3.0% (20/671 subjects) and 2.5% (17/685 subjects), respectively, compared to 0.9% (6/679 subjects) with placebo treatment. The increases in both celecoxib dose groups versus placebo-treated patients were mainly due to an increased incidence of myocardial infarction [see Clinical Studies].
To minimize the potential risk for an adverse CV event in NSAID-treated patients, use the lowest effective dose for the shortest duration possible. Physicians and patients should remain alert for the development of such events, throughout the entire treatment course, even in the absence of previous CV symptoms. Patients should be informed about the symptoms of serious CV events and the steps to take if they occur.
There is no consistent evidence that concurrent use of aspirin mitigates the increased risk of serious CV thrombotic events associated with NSAID use. The concurrent use of aspirin and an NSAID, such as celecoxib, increases the risk of serious gastrointestinal (GI) events [see Gastrointestinal Bleeding, Ulceration, And Perforation].
Status Post Coronary Artery Bypass Graft (CABG) Surgery
Two large, controlled clinical trials of a COX-2 selective NSAID for the treatment of pain in the first 10-14 days following CABG surgery found an increased incidence of myocardial infarction and stroke. NSAIDs are contraindicated in the setting of CABG [see CONTRAINDICATIONS].
Observational studies conducted in the Danish National Registry have demonstrated that patients treated with NSAIDs in the post-MI period were at increased risk of reinfarction, CV-related death, and all-cause mortality beginning in the first week of treatment. In this same cohort, the incidence of death in the first year post-MI was 20 per 100 person years in NSAID-treated patients compared to 12 per 100 person years in non-NSAID exposed patients. Although the absolute rate of death declined somewhat after the first year post-MI, the increased relative risk of death in NSAID users persisted over at least the next four years of follow-up.
Avoid the use of Celebrex in patients with a recent MI unless the benefits are expected to outweigh the risk of recurrent CV thrombotic events. If Celebrex is used in patients with a recent MI, monitor patients for signs of cardiac ischemia.
Gastrointestinal Bleeding, Ulceration, And Perforation
NSAIDs, including celecoxib cause serious gastrointestinal (GI) adverse events including inflammation, bleeding, ulceration, and perforation of the esophagus, stomach, small intestine, or large intestine, which can be fatal. These serious adverse events can occur at any time, with or without warning symptoms, in patients treated with CELEBREX. Only one in five patients who develop a serious upper GI adverse event on NSAID therapy is symptomatic. Upper GI ulcers, gross bleeding, or perforation caused by NSAIDs occurred in approximately 1% of patients treated for 3-6 months, and in about 2%-4% of patients treated for one year. However, even short-term NSAID therapy is not without risk.
Risk Factors For GI Bleeding, Ulceration, And Perforation
Patients with a prior history of peptic ulcer disease and/or GI bleeding who used NSAIDs had a greater than 10-fold increased risk for developing a GI bleed compared to patients without these risk factors. Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants; or selective serotoninreuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. Most postmarketing reports of fatal GI events occurred in elderly or debilitated patients. Additionally, patients with advanced liver disease and/or coagulopathy are at increased risk for GI bleeding.
Complicated and symptomatic ulcer rates were 0.78% at nine months for all patients in the CLASS trial, and 2.19% for the subgroup on low-dose ASA. Patients 65 years of age and older had an incidence of 1.40% at nine months, 3.06% when also taking ASA [seeClinical Studies].
Strategies to Minimize the GI Risks in NSAID-treated patients:
- Use the lowest effective dosage for the shortest possible duration.
- Avoid administration of more than one NSAID at a time.
- Avoid use in patients at higher risk unless benefits are expected to outweigh the increased risk of bleeding. For such patients, as well as those with active GI bleeding, consider alternate therapies other than NSAIDs.
- Remain alert for signs and symptoms of GI ulceration and bleeding during NSAID therapy.
- If a serious GI adverse event is suspected, promptly initiate evaluation and treatment, and discontinue CELEBREX until a serious GI adverse event is ruled out.
- In the setting of concomitant use of low-dose aspirin for cardiac prophylaxis, monitor patients more closely for evidence of GI bleeding [seeDRUG INTERACTIONS].
Elevations of ALT or AST (three or more times the upper limit of normal [ULN]) have been reported in approximately 1% of NSAID-treated patients in clinical trials. In addition, rare, sometimes fatal, cases of severe hepatic injury, including fulminant hepatitis, liver necrosis, and hepatic failure have been reported.
Elevations of ALT or AST (less than three times ULN) may occur in up to 15% of patients treated with NSAIDs including celecoxib.
In controlled clinical trials of CELEBREX, the incidence of borderline elevations (greater than or equal to 1.2 times and less than 3 times the upper limit of normal) of liver associated enzymes was 6% for CELEBREX and 5% for placebo, and approximately 0.2% of patients taking CELEBREX and 0.3% of patients taking placebo had notable elevations of ALT and AST.
Inform patients of the warning signs and symptoms of hepatotoxicity (e.g., nausea, fatigue, lethargy, diarrhea, pruritus, jaundice, right upper quadrant tenderness, and “flu-like” symptoms). If clinical signs and symptoms consistent with liver disease develop, or if systemic manifestations occur (e.g., eosinophilia, rash, etc.), discontinue CELEBREX immediately, and perform a clinical evaluation of the patient.
NSAIDs, including CELEBREX can lead to new onset of hypertension or worsening of preexisting hypertension, either of which may contribute to the increased incidence of CV events. Patients taking angiotensin converting enzyme (ACE) inhibitors, thiazide diuretics or loop diuretics may have impaired response to these therapies when taking NSAIDs [seeDRUG INTERACTIONS].
The rates of hypertension from the CLASS trial in the CELEBREX, ibuprofen and diclofenac-treated patients were 2.4%, 4.2% and 2.5%, respectively [seeClinical Studies].
Monitor blood pressure (BP) during the initiation of NSAID treatment and throughout the course of therapy.
Heart Failure And Edema
The Coxib and traditional NSAID Trialists' Collaboration meta-analysis of randomized controlled trials demonstrated an approximately twofold increase in hospitalizations for heart failure in COX-2 selective-treated patients and nonselective NSAID-treated patients compared to placebo-treated patients. In a Danish National Registry study of patients with heart failure, NSAID use increased the risk of MI, hospitalization for heart failure, and death.
Additionally, fluid retention and edema have been observed in some patients treated with NSAIDs. Use of celecoxib may blunt the CV effects of several therapeutic agents used to treat these medical conditions (e.g., diuretics, ACE inhibitors, or angiotensin receptor blockers [ARBs]) [seeDRUG INTERACTIONS].
In the CLASS study [seeClinical Studies], the Kaplan-Meier cumulative rates at 9 months of peripheral edema in patients on CELEBREX 400 mg twice daily (4-fold and 2-fold the recommended OA and RA doses, respectively), ibuprofen 800 mg three times daily and diclofenac 75 mg twice daily were 4.5%, 6.9% and 4.7%, respectively.
Avoid the use of CELEBREX in patients with severe heart failure unless the benefits are expected to outweigh the risk of worsening heart failure. If CELEBREX is used in patients with severe heart failure, monitor patients for signs of worsening heart failure.
Renal Toxicity And Hyperkalemia
Long-term administration of NSAIDs has resulted in renal papillary necrosis and other renal injury.
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. In these patients, administration of an NSAID may cause a dose-dependent reduction in prostaglandin formation and, secondarily, in renal blood flow, which may precipitate overt renal decompensation. Patients at greatest risk of this reaction are those with impaired renal function, dehydration, hypovolemia, heart failure, liver dysfunction, those taking diuretics, ACE-inhibitors or the ARBs, and the elderly. Discontinuation of NSAID therapy is usually followed by recovery to the pretreatment state.
No information is available from controlled clinical studies regarding the use of CELEBREX in patients with advanced renal disease. The renal effects of CELEBREX may hasten the progression of renal dysfunction in patients with preexisting renal disease.
Correct volume status in dehydrated or hypovolemic patients prior to initiating CELEBREX. Monitor renal function in patients with renal or hepatic impairment, heart failure, dehydration, or hypovolemia during use of CELEBREX [see DRUG INTERACTIONS]. Avoid the use of CELEBREX in patients with advanced renal disease unless the benefits are expected to outweigh the risk of worsening renal function. If CELEBREX is used in patients with advanced renal disease, monitor patients for signs of worsening renal function.
Increases in serum potassium concentration, including hyperkalemia, have been reported with use of NSAIDs, even in some patients without renal impairment. In patients with normal renal function, these effects have been attributed to a hyporeninemic- hypoadosteronism state.
Celecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celebrex is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeCONTRAINDICATIONS and Exacerbation Of Asthma Related To Aspirin Sensitivity].
Seek emergency help if any anaphylactic reaction occurs.
Exacerbation Of Asthma Related To Aspirin Sensitivity
A subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, CELEBREX is contraindicated in patients with this form of aspirin sensitivity [see CONTRAINDICATIONS]. When CELEBREX is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.
Serious Skin Reactions
Serious skin reactions have occurred following treatment with Celebrex, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.
Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of CELEBREX at the first appearance of skin rash or any other sign of hypersensitivity. CELEBREX is contraindicated in patients with previous serious skin reactions to NSAIDs [see CONTRAINDICATIONS].
Premature Closure Of Fetal Ductus Arteriosus
Celecoxib may cause premature closure of the ductus arteriosus. Avoid use of NSAIDs, including CELEBREX, in pregnant women starting at 30 weeks of gestation (third trimester) [see Use In Specific Populations].
Anemia has occurred in NSAID-treated patients. This may be due to occult or gross blood loss, fluid retention, or an incompletely described effect on erythropoiesis. If a patient treated with CELEBREX has any signs or symptoms of anemia, monitor hemoglobin or hematocrit.
In controlled clinical trials the incidence of anemia was 0.6% with CELEBREX and 0.4% with placebo. Patients on long-term treatment with CELEBREX should have their hemoglobin or hematocrit checked if they exhibit any signs or symptoms of anemia or blood loss.
NSAIDs, including CELEBREX, may increase the risk of bleeding events. Co-morbid conditions such as coagulation disorders or concomitant use of warfarin, other anticoagulants, antiplatelet agents (e.g., aspirin), serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) may increase this risk. Monitor these patients for signs of bleeding [see DRUG INTERACTIONS].
Masking Of Inflammation And Fever
The pharmacological activity of CELEBREX in reducing inflammation, and possibly fever, may diminish the utility of diagnostic signs in detecting infections.
Because serious GI bleeding, hepatotoxicity, and renal injury can occur without warning symptoms or signs, consider monitoring patients on long-term NSAID treatment with a CBC and a chemistry profile periodically.
In controlled clinical trials, elevated BUN occurred more frequently in patients receiving CELEBREX compared with patients on placebo. This laboratory abnormality was also seen in patients who received comparator NSAIDs in these studies. The clinical significance of this abnormality has not been established.
Disseminated Intravascular Coagulation (DIC)
Because of the risk of disseminated intravascular coagulation with use of CELEBREX in pediatric patients with systemic onset JRA, monitor patients for signs and symptoms of abnormal clotting or bleeding, and inform patients and their caregivers to report symptoms as soon as possible.
Patient Counseling Information
Advise the patient to read the FDA-approved patient labeling (Medication Guide) that accompanies each prescription dispensed. Inform patients, families, or their caregivers of the following information before initiating therapy with CELEBREX and periodically during the course of ongoing therapy.
Cardiovascular Thrombotic Events
Advise patients to be alert for the symptoms of cardiovascular thrombotic events, including chest pain, shortness of breath, weakness, or slurring of speech, and to report any of these symptoms to their health care provider immediately [see WARNINGS AND PRECAUTIONS].
Gastrointestinal Bleeding, Ulceration, And Perforation
Advise patients to report symptoms of ulcerations and bleeding, including epigastric pain, dyspepsia, melena, and hematemesis to their health care provider. In the setting of concomitant use of low-dose aspirin for cardiac prophylaxis, inform patients of the increased risk for and the signs and symptoms of GI bleeding [see WARNINGS AND PRECAUTIONS].
Inform patients of the warning signs and symptoms of hepatotoxicity (e.g., nausea, fatigue, lethargy, pruritus, diarrhea jaundice, right upper quadrant tenderness, and “flu-like” symptoms). If these occur, instruct patients to stop CELEBREX and seek immediate medical therapy [see WARNINGS AND PRECAUTIONS, Use in Specific Populations].
Heart Failure And Edema
Advise patients to be alert for the symptoms of congestive heart failure including shortness of breath, unexplained weight gain, or edema and to contact their healthcare provider if such symptoms occur [see WARNINGS AND PRECAUTIONS].
Inform patients of the signs of an anaphylactic reaction (e.g., difficulty breathing, swelling of the face or throat). Instruct patients to seek immediate emergency help if these occur [see CONTRAINDICATIONS and WARNINGS AND PRECAUTIONS].
Serious Skin Reactions
Advise patients to stop CELEBREX immediately if they develop any type of rash and to contact their healthcare provider as soon as possible [see WARNINGS AND PRECAUTIONS].
Advise females of reproductive potential who desire pregnancy that NSAIDs, including CELEBREX, may be associated with a reversible delay in ovulation [see Use In Specific Populations].
Inform pregnant women to avoid use of CELEBREX and other NSAIDs starting at 30 weeks of gestation because of the risk of the premature closing of the fetal ductus arteriosus [see WARNINGS AND PRECAUTIONS and Use In Specific Populations].
Avoid Concomitant Use Of NSAIDs
Inform patients that the concomitant use of CELEBREX with other NSAIDs or salicylates (e.g., diflunisal, salsalate) is not recommended due to the increased risk of gastrointestinal toxicity, and little or no increase in efficacy [see WARNINGS AND PRECAUTIONS and DRUG INTERACTIONS]. Alert patients that NSAIDs may be present in “over the counter” medications for treatment of colds, fever, or insomnia.
Use Of NSAIDS And Low-Dose Aspirin
Inform patients not to use low-dose aspirin concomitantly with CELEBREX until they talk to their healthcare provider [seeDRUG INTERACTIONS].
Carcinogenesis, Mutagenesis, Impairment Of Fertility
Celecoxib was not carcinogenic in Sprague-Dawley rats given oral doses up to 200 mg/kg for males and 10 mg/kg for females (approximately 2-to 4-times the human exposure as measured by the AUC0-24 at 200 mg twice daily) or in mice given oral doses up to 25 mg/kg for males and 50 mg/kg for females (approximately equal to human exposure as measured by the AUC0-24 at 200 mg twice daily) for two years.
Celecoxib was not mutagenic in an Ames test and a mutation assay in Chinese hamster ovary (CHO) cells, nor clastogenic in a chromosome aberration assay in CHO cells and an in vivo micronucleus test in rat bone marrow.
Impairment Of Fertility
Celecoxib had no effect on male or female fertility or male reproductive function in rats at oral doses up to 600 mg/kg/day (approximately 11times human exposure at 200 mg twice daily based on the AUC0-24). At ≥ 50 mg/kg/day (approximately 6-times human exposure based on the AUC0-24 at 200 mg twice daily) there was increased preimplantation loss.
Use In Specific Populations
Pregnancy Category C. Pregnancy category D from 30 weeks of gestation onward.
Use of NSAIDs, including CELEBREX, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. Avoid use of NSAIDs, including CELEBREX, in pregnant women starting at 30 weeks of gestation.
There are no adequate and well-controlled studies of CELEBREX in pregnant women. Data from observational studies regarding potential embryofetal risks of NSAID use in women in the first or second trimesters of pregnancy are inconclusive. In the general U.S. population, all clinically recognized pregnancies, regardless of drug exposure, have a background rate of 2-4% for major malformations, and 15-20% for pregnancy loss. In animal reproduction studies, embryo-fetal deaths and an increase in diaphragmatic hernias were observed in rats administered celecoxib daily during the period of organogenesis at oral doses approximately 6 times the maximum recommended human dose of 200 mg twice daily. In addition, structural abnormalities (e.g., septal defects, ribs fused, sternebrae fused and sternebrae misshapen) were observed in rabbits given daily oral doses of celecoxib during the period of organogenesis at approximately 2 times the MRHD [see Data]. Based on animal data, prostaglandins have been shown to have an important role in endometrial vascular permeability, blastocystimplantation, and decidualization. In animal studies, administration of prostaglandin synthesis inhibitors such as celecoxib, resulted in increased pre- and post-implantation loss.
Labor or Delivery
There are no studies on the effects of CELEBREX during labor or delivery. In animal studies, NSAIDs, including celecoxib, inhibit prostaglandin synthesis, cause delayed parturition, and increase the incidence of stillbirth.
The available data do not establish the presence or absence of developmental toxicity related to the use of Celebrex.
Celecoxib at oral doses ≥ 150 mg/kg/day (approximately 2 times the human exposure at 200 mg twice daily as measured by AUC0-24), caused an increased incidence of ventricular septal defects, a rare event, and fetal alterations, such as ribs fused, sternebrae fused and sternebrae misshapen when rabbits were treated throughout organogenesis. A dose-dependent increase in diaphragmatic hernias was observed when rats were given celecoxib at oral doses ≥ 30 mg/kg/day (approximately 6 times human exposure based on the AUC0-24 at 200 mg twice daily for RA) throughout organogenesis. In rats, exposure to celecoxib during early embryonic development resulted in pre-implantation and post-implantation losses at oral doses ≥ 50 mg/kg/day (approximately 6 times human exposure based on the AUC0-24 at 200 mg twice daily for RA).